CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Chernett Jorey 10% owner | Sale | −2,851,061 | $3.99 | $11.4M | 7,809,797 |
| 2026-08-21 | Hively Brad Director | Sale 10b5-1 | −298,853 | $6.51 | $1.9M | 411,976 |
| 2026-07-14 | Podnos Yale Chief Medical Officer | Sale 10b5-1 | −17,974 | $6.43 | $116K | 259,527 |
| 2026-07-14 | Podnos Yale Chief Medical Officer | Sale 10b5-1 | −5,478 | $6.35 | $35K | 259,527 |
| 2026-06-08 | Podnos Yale Chief Medical Officer | Sale 10b5-1 | −23,451 | $5.38 | $126K | 259,527 |
| 2026-04-16 | Kaushal Mohit Director | Sale 10b5-1 | −38,433 | $3.50 | $135K | 172,583 |
| 2026-04-14 | Kaushal Mohit Director | Sale 10b5-1 | −57,286 | $3.50 | $201K | 211,016 |
| 2026-01-02 | Carter Robert Ross Chief Financial Officer | Sale | −247 | $3.56 | $879 | 235,122 |
| 2025-12-15 | Hively Brad Director | Sale | −13,333 | $3.77 | $50K | 683,721 |
| 2025-11-18 | Pacala Mark L Director | Sale | −2,160 | $4.00 | $9K | 222,811 |
| 2025-11-18 | Pacala Mark L Director | Sale | −1,210 | $4.00 | $5K | 221,601 |
| 2025-11-18 | Pacala Mark L Director | Sale | −46,630 | $4.00 | $187K | 174,971 |
| 2025-09-04 | M33 Growth I L.P. Director | Sale | −6,018,168 | $3.09 | $18.6M | 7,932,389 |
| 2025-09-04 | M33 Growth I L.P. Director | Sale | −681,832 | $3.09 | $2.1M | 590,892 |
| 2025-08-19 | Hively Brad Director | Sale | −20,221 | $4.06 | $82K | 622,980 |
| 2025-06-05 | M33 Growth I L.P. Director | Sale | −673,676 | $3.05 | $2.1M | 13,950,557 |
| 2025-06-05 | M33 Growth I L.P. Director | Sale | −76,324 | $3.05 | $233K | 1,272,724 |
| 2025-06-03 | Hively Brad Director | Sale | −1,867,605 | $2.87 | $5.4M | 712,033 |
| 2025-06-03 | Hively Brad Director | Sale | −108,532 | $2.87 | $312K | 603,501 |
| 2025-05-20 | M33 Growth I L.P. Director | Sale | −1,796,468 | $2.71 | $4.9M | 14,624,233 |
Page 1 of 2 · 21 trades